Edition:
United Kingdom

Avinger Inc (AVGR.OQ)

AVGR.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
20 Jun 2018
Change (% chg)

$-0.02 (-1.22%)
Prev Close
$1.64
Open
$1.65
Day's High
$1.65
Day's Low
$1.58
Volume
18,689
Avg. Vol
276,664
52-wk High
$38.00
52-wk Low
$0.95

Latest Key Developments (Source: Significant Developments)

Avinger Receives FDA Clearance Of Next Generation Pantheris Device
Wednesday, 23 May 2018 

May 23 (Reuters) - Avinger Inc ::AVINGER RECEIVES FDA CLEARANCE OF NEXT GENERATION PANTHERIS DEVICE.AVINGER - DISTRIBUTION OF PANTHERIS WILL BE EXPANDED AS CO INCREASES PRODUCTION AND GAINS PURCHASING APPROVALS IN ADDITIONAL LUMIVASCULAR SITES.  Full Article

Avinger Inc Files For Common Stock Offering Of Up To $15 Mln
Friday, 12 Jan 2018 

Jan 12 (Reuters) - Avinger Inc ::AVINGER INC FILES FOR COMMON STOCK OFFERING OF UP TO $15.0 MILLION - SEC FILING.  Full Article

Avinger Says Executive Chairman John Simpson Will Be Leaving Company
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Avinger Inc ::AVINGER ANNOUNCES CHANGE IN BOARD LEADERSHIP.AVINGER INC - JOHN B. SIMPSON, FOUNDER AND EXECUTIVE CHAIRMAN OF AVINGER, WILL BE LEAVING COMPANY.AVINGER INC - CONCURRENT WITH SIMPSON'S DEPARTURE, JAMES G. CULLEN HAS BEEN APPOINTED NON-EXECUTIVE CHAIRMAN OF BOARD.  Full Article

Avinger Q3 loss per share $0.43
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Avinger Inc ::Avinger announces third quarter 2017 results.Q3 loss per share $0.43.Q3 revenue fell 61 percent to $2.1 million.Avinger Inc - ‍cash and cash equivalents totaled $10.2 million as of Sept 30, 2017, compared to $14.0 million as of June 30, 2017​.  Full Article

Avinger says it entered into purchase agreement, registration rights agreement
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Avinger Inc ::Co entered into purchase agreement, registration rights agreement for up to $15.0 million worth of stock, $0.001 par value per share​.  Full Article

Avinger says ‍received 510(k) clearance from U.S. FDA for modifications to co's pantheris lumivascular atherectomy system​
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Avinger Inc :Avinger Inc says ‍received 510(k) clearance from U.S. FDA for modifications to co's pantheris lumivascular atherectomy system​.  Full Article

Avinger announces pricing of public offering of common stock
Thursday, 11 Aug 2016 

Avinger Inc : Avinger Inc announces pricing of public offering of common stock .Says public offering of 8.57 million common shares priced at $3.50per share.  Full Article

Avinger Inc Announces proposed public offering of common stock
Wednesday, 10 Aug 2016 

Avinger Inc :Avinger, Inc. Announces proposed public offering of common stock.  Full Article

Avinger says qtrly loss per share $1.06
Monday, 1 Aug 2016 

Avinger Inc : Avinger Inc announces second quarter 2016 results . Q2 revenue $4.7 million versus I/B/E/S view $5.7 million . Sees FY 2016 revenue $19 million to $23 million . Sees FY 2016 loss per share $4.35 to $4.55 . Qtrly loss per share $1.06 . Q2 earnings per share view $-1.15, revenue view $5.0 million -- Thomson Reuters I/B/E/S . Says adjusted EBITDA for 2016 is projected to be a loss of $40 million to $43 million .FY 2016 earnings per share view $-4.26, revenue view $22.0 million -- Thomson Reuters I/B/E/S.  Full Article

Avinger announces preliminary Q2 2016 revenue results
Tuesday, 12 Jul 2016 

Avinger Inc : Avinger Inc announces preliminary second quarter 2016 revenue results . Sees Q2 2016 revenue about $4.7 million . Sees FY 2016 revenue $19 million to $23 million . Q2 revenue view $5.7 million -- Thomson Reuters I/B/E/S .FY2016 revenue view $28.3 million -- Thomson Reuters I/B/E/S.  Full Article